Back to Journals » Patient Preference and Adherence » Volume 2

Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes

Authors Athena Philis-Tsimikas

Published 2 November 2008 Volume 2008:2 Pages 323—332

DOI https://doi.org/10.2147/PPA.S3293

Review by Single-blind

Peer reviewer comments 4

Athena Philis-Tsimikas

Scripps Whittier Diabetes Institute, La Jolla, CA, USA

Abstract: The progressive nature of type 2 diabetes poses challenges in the clinic: treatment must be continually reviewed and adjusted in response to the patient’s changing pathophysiology. Ultimately, insulin replacement therapy will be necessary as the physiological insulin response is compromised. The modern basal insulin analog insulin detemir has been the subject of several clinical trials and observational studies in type 2 diabetes. Compared with NPH insulin, insulin detemir offers an improved balance between achieving current glycemic targets with acceptable tolerability. Insulin detemir also has a unique weight-sparing effect which is associated with body mass index, and this may be a particular advantage to obese patients with type 2 diabetes. This review summarizes data from key clinical studies of insulin detemir, and also provides insights from observational studies.

Keywords: type 2 diabetes mellitus, insulin detemir, modern analog, basal insulin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Design and development of a decision aid to enhance shared decision making by patients with an asymptomatic abdominal aortic aneurysm

Dirk T Ubbink, Anouk M Knops, Sjaak Molenaar, Astrid Goossens

Patient Preference and Adherence 2008, 2:315-322

Published Date: 2 November 2008

Reasons for noncompliance with five-yearly screening flexible sigmoidoscopy

Charlie Henri Viiala, John Kevin Olynyk

Patient Preference and Adherence 2008, 2:27-33

Published Date: 30 October 2008

Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes

Marie A Chisholm-Burns, Christina A Spivey, Charlene Garrett, Herbert McGinty, Laura L Mulloy

Patient Preference and Adherence 2008, 2:287-292

Published Date: 17 October 2008

Health professionals’ experiences of person-centered collaboration in mental health care

Rita Sommerseth, Elin Dysvik

Patient Preference and Adherence 2008, 2:259-269

Published Date: 9 October 2008

Are symbols useful and culturally acceptable in health-state valuation studies? An exploratory study in a multi-ethnic Asian population

Hwee-Lin, Wee, Shu-Chuen Li, Xu-Hao Zhang, Feng Xie, David Feeny, et al

Patient Preference and Adherence 2008, 2:271-276

Published Date: 2 October 2008

Communication training and patient satisfaction: A randomized trial study from Mashhad, Iran

Nahid Ahmadian Yazdi, Sedigheh Sadat Tavafian, Ali Emadzadeh, Anooshirvan Kazemnejad, Fazlollah Ghofranipour

Patient Preference and Adherence 2008, 2:137-142

Published Date: 8 April 2008

Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program

Susan M Abughosh, Stephen J Kogut

Patient Preference and Adherence 2008, 2:79-85

Published Date: 20 March 2008

Adherence to glatiramer acetate treatment for multiple sclerosis: the Brazilian experience

Tatiana de Melo Gomes de Oliveira, Ana Patricia Peres Fiore, Yára Dadalti Fragoso

Patient Preference and Adherence 2008, 2:41-46

Published Date: 5 March 2008